Divi's Laboratories (NSE:DIVISLAB) Other Current Liabilities: ₹8,180 Mil (As of Mar. 2026)


NSE:DIVISLAB Divi's Laboratories Ltd NSE:DIVISLAB
94 GF Score
Price ₹6,545.50
GF Value ₹6,749.79
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Divi's Laboratories Other Current Liabilities?

Divi's Laboratories NSE:DIVISLAB -0.51% 94 Other Current Liabilities is ₹8,180 Mil as of Mar. 2026. GuruFocus rates NSE:DIVISLAB with a GF Score™ of 94/100 and a GF Value™ of ₹6,749.79 (Fairly Valued). The stock has 5 warning signs investors should review.

Divi's Laboratories's other current liabilities for the quarter that ended in Mar. 2026 was ₹8,180 Mil.

Divi's Laboratories's quarterly other current liabilities declined from Sep. 2025 (₹5,530 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹8,180 Mil).

Divi's Laboratories's annual other current liabilities increased from Mar. 2024 (₹730 Mil) to Mar. 2025 (₹1,140 Mil) and increased from Mar. 2025 (₹1,140 Mil) to Mar. 2026 (₹8,180 Mil).

Divi's Laboratories Other Current Liabilities Related Terms

Divi's Laboratories Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Divi's Laboratories's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Divi's Laboratories Other Current Liabilities Chart

Divi's Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 279.30 550.00 730.00 1,140.00 8,180.00

Divi's Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,140.00 0.00 5,530.00 0.00 8,180.00
NSE:DIVISLAB
94GF Score
Divi's Laboratories Ltd NSE:DIVISLAB
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Divi's Laboratories Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₹8,180 Mil mean?
Divi's Laboratories (NSE:DIVISLAB) has a Other Current Liabilities of ₹8,180 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Divi's Laboratories.
Is Divi's Laboratories' Other Current Liabilities too high?
Divi's Laboratories' current Other Current Liabilities is ₹8,180 Mil. Overall, Divi's Laboratories has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Divi's Laboratories' Other Current Liabilities compare to ZTS and UTHR?
Divi's Laboratories' Other Current Liabilities of ₹8,180 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Divi's Laboratories. Divi's Laboratories's current Other Current Liabilities is ₹8,180 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Divi's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Divi's Laboratories (NSE:DIVISLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹6,749.79, compared to a current price of ₹6,545.50 — trading 3% below its estimated fair value. The current Other Current Liabilities is ₹8,180 Mil. Divi's Laboratories' overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Divi's Laboratories (NSE:DIVISLAB), the current Other Current Liabilities is ₹8,180 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Divi's Laboratories (NSE:DIVISLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Divi's Laboratories stock appears to be undervalued. The current stock price of ₹6,545.50 is trading 3% below its estimated GF Value™ of ₹6,749.79. GuruFocus considers Divi's Laboratories to be Fairly Valued.

Key valuation signals for NSE:DIVISLAB:

  • Other Current Liabilities: ₹8,180 Mil
  • GF Value™: ₹6,749.79 vs. price of ₹6,545.50 (3% below fair value)
  • GF Score™: 94/100 with 5 warning signs

No single metric tells the full story. See the NSE:DIVISLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Divi's Laboratories Business Description

Other Exchanges 532488:India
Address Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
94GF Score

Get the complete analysis for NSE:DIVISLAB

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6,545.50
Price
₹6,749.79
GF Value